Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: Implications for tissue engineering heart valve construction

Artificial Organs

Volumn 34, Issue 3, 2010, Pages 215-222

  Xin, Yuan ^a,b   Wang, Yu Mei ^b,c   Zhang, Hao ^a,b   Li, Jun ^b   Wang, Wei ^a   Wei, Ying Jie ^b   Hu, Sheng Shou ^a,b  

^a FUWAI HOSPITAL   (China)

^b MINISTRY OF HEALTH   (New Zealand)

^c First Affiliated Hospital of PLA General   (China)

Author keywords

Aging; Cell proliferation; Implants; Mesenchymal stem cell; Tissue engineering

Indexed keywords

BONE; CELL ENGINEERING; CELL PROLIFERATION; ENDOTHELIAL CELLS; HEART; OSTEOBLASTS; STEM CELLS; TISSUE ENGINEERING;

BIOLOGICAL PROPERTIES; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS; COLONY FORMING UNITS; GROWTH CURVES; HEART VALVES; IMPLANT; MESENCHYMAL STEM CELL; TISSUES ENGINEERINGS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CELL CULTURE;

BROXURIDINE; CYTOKINE; VASCULOTROPIN;

ADIPOCYTE; ADOLESCENT; ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL AGING; CELL ASSAY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; GROUPS BY AGE; GROWTH CURVE; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MIDDLE AGED; MORPHOLOGY; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RHEUMATIC HEART DISEASE; SCHOOL CHILD; TISSUE ENGINEERING; VALVULAR HEART DISEASE;

EID: 77949667221     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00824.x     Document Type: Article

References (23)

1. Prockop D. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 276 : 71 4.
2. Vincentelli A, Wautot F, Juthier F, et al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 2007 134 : 424 432.
3. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004 109 : 1615 1622.
4. Hou M, Yang KM, Zhang H, et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007 115 : 220 228.
5. Zhang H, Fazel S, Tian H, et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 2005 289 : 2089 2096.
6. Hou J, Zhang H, Yuan X, Li J, Wei YJ, Hu SS. In vitro effects of low-level laser irradiation for bone marrow mesenchymal stem cells: proliferation, growth factors secretion and myogenic differentiation. Lasers Surg Med 2008 40 : 726 733.
7. Su W, Zhang H, Jia Z, Zhou C, Wei Y, Hu S. Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium? Stem Cells 2006 24 : 349 356.
8. Zhang G, Zhou J, Fan Q, et al. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation. FEBS Lett 2008 582 : 2957 2964.
9. Zhang S, Zhang H, Hou M, et al. Is it possible to obtain "true endothelial progenitor cells" by in vitro culture of bone marrow mononuclear cells? Stem Cells Dev 2007 16 : 683 690.
10. Pittenger M, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 : 143 147.
11. Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006 24 : 416 425.
12. He G, Zhang H, Wei H, et al. In vivo imaging of bone marrow mesenchymal stem cells transplanted into myocardium using magnetic resonance imaging: a novel method to trace the transplanted cells. Int J Cardiol 2007 114 : 4 10.
13. Cohn L, Narayanasamy N. Aortic valve replacement in elderly patients: what are the limits? Curr Opin Cardiol 2007 22 : 92 5.
14. Yeghiazaryan K, Bauriedel G, Schild HH, Golubnitschaja O. Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus. Infect Disord Drug Targets 2008 8 : 88 99.
15. Shastri V. Future of regenerative medicine: challenges and hurdles. Artif Organs 2006 30 : 828 834.
16. Sutherland F, Perry TE, Yu Y, et al. From stem cells to viable autologous semilunar heart valve. Circulation 2005 111 : 2783 2791.
17. Fadini G, de Kreutzenberg SV, Coracina A, et al. Circulating CD341 cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006 27 : 2247 2255.
18. Oreffo R, Bennett A, Carr AJ, Triffitt JT. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand J Rheumatol 1998 27 : 415 424.
19. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008 129 : 163 173.
20. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003 33 : 919 926.
21. Gerber H, Malik AK, Solar GP, et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002 417 : 954 958.
22. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007 25 : 2739 2749.
23. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999 14 : 1115 1122.